Titre :
  • A randomized controlled phase ii trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (tnbc)
Auteur : Awada, Ahmad ; Piccart-Gebhart, Martine ; Bondarenko, Igor I.N. ; Bonneterre, Jacques J. ; Nowara, Elzbieta E. ; Ferrero, Jean Marc J.M. ; Bakshi, Ashish Vijay A.V. ; Wilke, Cailin Moira C.
Informations sur la publication : Annals of oncology, 25, 4, mdu025, (page 824-831)
Statut de publication : Publié, 2014
Sujet CREF : Hématologie
Cancérologie
Mots-clés : Activated tumor endothelial cells
Advanced disease
Cationic liposomes of paclitaxel
EndoTAG-1
Lipid-embedded paclitaxel
Triple-negative breast cancer
Mots-clés MeSH : Adult
Aged
Combined Modality Therapy
Disease-Free Survival
Drug-Related Side Effects and Adverse Reactions -- classification -- pathology
Endothelial Cells -- drug effects
Female
Humans
Lipids -- administration & dosage -- chemistry
Middle Aged
Paclitaxel -- administration & dosage -- chemistry
Triple Negative Breast Neoplasms -- drug therapy -- pathology
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdu025
info:pii/mdu025
info:pmid/24667715